The purpose of this program is to facilitate the direct testing of new treatments for schizophrenia and bipolar disorder. The deadline for treatment trial proposals is October 1 of each year. As of 2008, SMRI will no longer be accepting treatment trial proposals on March 1. The awards are granted for a maximum of $300,000 per year for up to three years, depending on the stage of development of the compounds to be tested and the type of trial required. Current and past treatment trials supported by SMRI can be viewed by clicking on the link below.

• List of Awarded Treatment Trials To view a brief description of a trial, click on the select button to the left of the grant identification number.  The list can be sorted by clicking on a column head.
  

• Applying for a treatment trial grant
  • Frequently asked questions
    
  • Treatment trial application
    
  
  
• Quarterly report forms for SMRI-funded treatment trials Funded investigators should use this form to provide quarterly updates on treatment trials.
  

Questions regarding treatment trials should be addressed to Ms. Rhoda Marte at marter@stanleyresearch.org.